FOR IMMEDIATE RELEASE
Bastiaan Driehuys, PhD, to Receive the Research Innovation and Translation Achievement Award
Dr. Driehuys will be formally recognized for his outstanding contributions to the field at the ATS 2025 International Conference in San Francisco.
NEW YORK, NY (May 15, 2025) -- The American Thoracic Society is proud to announce that Bastiaan Driehuys, PhD, will receive a 2025 ATS Respiratory Health Award. Dr. Driehuys will be presented with ATS’s Research Innovation and Translation Achievement Award for his exemplary achievements in respiratory health based on his work at Duke University Medical Center.
All award recipients will be recognized for their contributions and achievements in pulmonary disease, critical care and sleep medicine at the upcoming ATS 2025 International Conference to be held May 16-21 in San Francisco. The awards represent outstanding respiratory health contributions through various means, from research and diagnosis to education and advocacy.
"This year's ATS Respiratory Health Awards recipients embody excellence in science and clinical care," said ATS President Irina Petrache, MD, ATSF. "We extend our warmest congratulations to these outstanding individuals. Their work has made a meaningful difference in advancing respiratory health around the world, and we are deeply appreciative of their contributions."
Based in Durham, NC, Dr. Driehuys will receive the Research Innovation and Translation Achievement Award recognizing and celebrating an individual who has made substantial contributions to the advancement of respiratory research focused on specific innovations to improve health by advancing practice, policy and health care delivery, demonstrating real-world innovation with tangible benefits to address unmet respiratory health care needs. The award recognizes individual accomplishments, as well as their role as a leader pursuing team science through collaborative approaches, both interdisciplinary and inter-institutional.
“I am deeply honored to receive the 2025 Research Innovation and Translation Achievement Award,” Dr. Driehuys said. “This recognition reflects the dedication of an incredible community of interdisciplinary scientists and physicians who have advanced xenon MRI into a transformative tool for 3D assessment of pulmonary function. I’m excited to continue working with my ATS colleagues to bring this technology to bear on improving the care of patients worldwide.”
Register now to attend ATS 2025 and recognize this year’s outstanding recipients.
About the American Thoracic Society:
Founded in 1905, the American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education and advocacy. Core activities of the Society’s more than 16,000 members are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care. Key areas of member focus include developing clinical practice guidelines, hosting the annual International Conference, publishing four peer-reviewed journals, advocating for improved respiratory health globally, and developing an array of patient education and career development resources.
Please visit our website and join the ATS community on Twitter/X, Facebook, Instagram, LinkedIn and BlueSky.
###